```html

Quench Fever (Brucellosis) – A Complete Patient Guide

Overview

Quench fever, more commonly called brucellosis, is a bacterial infection caused by organisms of the genus Brucella. These bacteria are intracellular, meaning they live inside the body’s cells, which makes the infection difficult to clear without proper antibiotics.

The disease is zoonotic—transmitted from animals to humans—most often through unpasteurized dairy products, direct contact with infected livestock, or inhalation of contaminated aerosols. Brucellosis is a worldwide problem, particularly in the Mediterranean region, the Middle East, Central and South America, sub‑Saharan Africa, and parts of Asia.

Who it affects: Anyone who works with or lives near livestock (goats, sheep, cattle, camels, pigs) is at higher risk, as are people who consume raw milk or cheese. Occupational groups with the highest reported incidence include farmers, veterinarians, abattoir workers, and laboratory staff.

Prevalence: The World Health Organization (WHO) estimates 500,000–600,000 new human cases each year, with under‑reporting likely raising the true number. In the United States, the CDC records roughly 100–200 cases annually, mostly linked to travel or import of unpasteurized products (CDC, 2022). In endemic regions, seroprevalence rates of 5–15 % have been documented among pastoral communities.

Symptoms

Brucellosis is notorious for its “undulating fever” – a pattern of fever that rises, falls, and rises again. Symptoms can be non‑specific and may develop weeks to months after exposure, which often delays diagnosis.

• Fever – usually low‑grade (38–39 °C), intermittent, lasting weeks to months.
• Night sweats – profuse sweating, especially during fever spikes.
• Fatigue & weakness – persistent tiredness that interferes with daily activities.
• Musculoskeletal pain – aches in the back, hips, knees, or any large joint; may mimic arthritis.
• Headache – often dull and persistent.
• Chills – shivering episodes that accompany fever spikes.
• Loss of appetite & weight loss – gradual decline over weeks.
• Hepatosplenomegaly – enlargement of the liver and spleen, sometimes palpable.
• Acute orchitis (in men) – painful swelling of one or both testicles; occurs in 2–20 % of male patients.
• Neurological involvement (neurobrucellosis) – headache, meningitis‑like symptoms, peripheral neuropathy, or even psychiatric changes.
• Endocarditis – infection of the heart valves; rare (<1 % of cases) but carries high mortality.
• Reproductive complications – spontaneous abortions in pregnant women, though data are limited.

Because the clinical picture overlaps with many other infections (e.g., typhoid, malaria, tuberculosis), laboratory confirmation is essential.

Causes and Risk Factors

What causes brucellosis?

Human infection results from exposure to Brucella species:

• B. melitensis – most virulent; primarily from goats and sheep.
• B. abortus – associated with cattle.
• B. suis – linked to swine.
• B. canis – rare, transmitted from dogs.

The bacteria enter the body through:

• Ingestion of unpasteurized milk, cheese, yogurt, or other dairy products.
• Direct skin contact with infected animal tissues, birthing fluids, or aborted fetuses, especially when cuts or abrasions are present.
• Inhalation of aerosolized bacteria in laboratory or slaughterhouse settings.
• Rarely via sexual contact or blood transfusion.

Who is at higher risk?

• Livestock workers (farmers, shepherds, milking staff).
• Veterinarians and animal health technicians.
• Abattoir and meat‑processing employees.
• Laboratory personnel handling Brucella cultures.
• Travelers to endemic regions who consume raw dairy.
• People with open skin lesions who handle animals or animal products.

Diagnosis

Because symptoms are vague, clinicians rely on a combination of exposure history, clinical suspicion, and laboratory testing.

Laboratory tests

1. Serology – The most common initial test. Detects antibodies (IgM, IgG) against Brucella. The Standard Agglutination Test (SAT) and Enzyme‑Linked Immunosorbent Assay (ELISA) are widely used. A titer ≥1:160 in a patient with compatible symptoms is suggestive.
2. Blood culture – Gold standard for definitive diagnosis but has a low yield (15–70 %) because the bacteria are slow‑growing. Specialized media (e.g., Castaneda) and prolonged incubation (up to 6 weeks) improve detection.
3. Polymerase Chain Reaction (PCR) – Detects bacterial DNA directly from blood, bone marrow, or CSF. Provides rapid results with high specificity; increasingly used in reference labs.
4. Bone marrow culture – More sensitive than peripheral blood culture, especially in chronic disease.

Imaging (when needed)

• Chest X‑ray or CT if respiratory symptoms or suspected endocarditis.
• Ultrasound of abdomen to assess hepatosplenomegaly.
• MRI of brain/spine for neurobrucellosis.

Diagnostic criteria (CDC/WHO)

A confirmed case requires isolation of Brucella from a normally sterile site OR a 4‑fold rise in serologic titer plus compatible clinical syndrome. Probable cases meet serologic criteria alone when exposure history is clear.

Treatment Options

Because Brucella resides inside cells, combination antibiotic therapy is required to eradicate the organism and prevent relapses.

First‑line regimens (WHO recommendation)

• Doxycycline 100 mg orally twice daily + Rifampin 600–900 mg orally once daily for 6 weeks.
• Alternative: Doxycycline + Trimethoprim‑Sulfamethoxazole (TMP‑SMX) for patients who cannot tolerate rifampin.

Complicated disease

When the infection involves the central nervous system, bones/joints, or heart, a more aggressive regimen is needed:

• Doxycycline + Streptomycin** (1 g IM daily) for 2‑3 weeks, followed by doxycycline alone to complete 12 weeks.
• Or Doxycycline + Gentamicin** (5 mg/kg IV/IM daily) for 7–10 days, then continue doxycycline.

**Streptomycin and gentamicin are aminoglycosides; they require monitoring of renal function and hearing.

Supportive care

• Adequate hydration and antipyretics (acetaminophen) for fever.
• Analgesics (NSAIDs) for joint pain, unless contraindicated.
• Physical therapy for chronic arthralgia.

Duration of therapy

Typical treatment lasts 6–8 weeks for uncomplicated disease; up to 12 weeks (or longer) for osteoarticular, neuro, or endocardial involvement. Incomplete courses dramatically increase relapse rates (up to 30 %).

Monitoring

Serologic titers are repeated at 2, 4, and 6 months after therapy to confirm decline. Persistent high titers may indicate relapse, requiring re‑evaluation.

Living with Quench Fever (Brucellosis)

Although antibiotics are curative for most, some patients experience lingering fatigue, joint pain, or mood changes—often termed “post‑brucellosis syndrome.” Below are practical tips for daily management.

Medication adherence

• Set alarms or use a pill‑organizer for twice‑daily doxycycline.
• Take tetracyclines with a full glass of water, on an empty stomach, and avoid lying down for 30 minutes to prevent esophageal irritation.
• Never stop antibiotics early, even if you feel better.

Managing fatigue and pain

• Prioritize rest; schedule short naps if needed.
• Gentle aerobic activity (walking, swimming) improves stamina without over‑taxing joints.
• Apply warm compresses or take warm baths for muscle soreness.
• Consider a referral to a physical therapist for targeted strengthening exercises.

Nutrition

• Eat a balanced diet rich in protein, vitamins C and D, and omega‑3 fatty acids to support immune recovery.
• Avoid raw or unpasteurized dairy products for the duration of treatment and at least 6 months afterward.

Psychological well‑being

• Persistent low‑grade fever and fatigue can cause anxiety or depression. Discuss mood changes with your provider.
• Support groups or online forums for brucellosis patients can reduce isolation.

Follow‑up appointments

• Initial 2‑week visit to assess drug tolerance and lab safety (liver enzymes, renal function).
• End‑of‑therapy visit for clinical exam and repeat serology.
• Long‑term check‑ups (every 6‑12 months) if you had complications or relapses.

Prevention

Because brucellosis is acquired from animals or animal products, prevention focuses on food safety and occupational protection.

Food‑borne prevention

• Consume only pasteurized milk, cheese, yogurt, and dairy derivatives.
• Boil raw milk for at least 1 minute if pasteurization status is uncertain.
• Avoid eating raw or undercooked meat from endemic regions.

Occupational protection

• Wear appropriate personal protective equipment (gloves, long sleeves, face shields) when handling birthing fluids, aborted fetuses, or carcasses.
• Implement rigorous hand‑washing after animal contact.
• Use respiratory protection (N95 or higher) in high‑aerosol settings such as laboratories or slaughterhouses.
• Vaccinate livestock where national programs exist (e.g., B. melitensis Rev.1 vaccine for goats/sheep).
• Ensure laboratory safety level 3 (BSL‑3) practices for cultures, as Brucella is a potential bioterrorism agent.

Public‑health measures

• Support animal‑health surveillance programs that test herds for brucellosis.
• Report suspected human cases to local health authorities; early case detection reduces spread.

Complications

If untreated or inadequately treated, brucellosis can spread to various organ systems, often months after initial infection.

• Osteoarticular disease – chronic arthritis, sacroiliitis, or spondylitis; may cause permanent joint damage.
• Neurobrucellosis – meningitis, encephalitis, myelitis, or peripheral neuropathy; can lead to persistent neurological deficits.
• Endocarditis – infection of heart valves, most commonly the aortic valve; carries a mortality >30 % without surgery.
• Hepatobiliary involvement – hepatitis, liver abscesses, or cholangitis.
• Genitourinary infection – orchitis, epididymitis, prostatitis, or infertility in men; spontaneous abortion or infertility in women.
• Chronic fatigue syndrome‑like picture – lasting months to years, affecting quality of life.

Early diagnosis and a full course of appropriate antibiotics dramatically reduce the risk of these outcomes.

When to Seek Emergency Care

References

• Mayo Clinic. Brucellosis: Symptoms & Causes. Accessed May 2024.
• Centers for Disease Control and Prevention (CDC). Brucellosis – About. Updated 2022.
• World Health Organization. Brucellosis Fact Sheet. 2023.
• National Institutes of Health (NIH) – National Library of Medicine. Clinical Management of Human Brucellosis. 2020.
• Cleveland Clinic. Brucellosis. Reviewed 2023.
• Alton, G.G., et al. “Brucellosis.” Lancet, vol. 370, no. 9578, 2007, pp. 1171‑1180.
• WHO. Brucellosis: Zoonotic Diseases. 2022.

```